Menu
Not yet recruiting NCT06736873

Effect of Light Color on Stress, Anxiety, and Psychological Well-being During Nonstress Test in Pregnant Women at Risk

No phase Interventional Pregnant Women Stress Light

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Light intervention.
Who it may be relevant to
Registry conditions: Pregnant Women, Stress, Light. Basic parameters: 18 Hours — 45 Hours · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effect of Light Color on Stress, Anxiety, and Psychological Well-being During Nonstress Test in Pregnant Women at Risk: A Randomized Placebo-controlled Study

Overview

Purpose of the research: To determine the effect of light color on stress, anxiety, and psychological well-being during the Nonstress Test in at-risk pregnant women. This research was planned as a single-blind randomized controlled experimental type study by comparing separate groups in the form of experiment-placebo control. Data will be collected with the Introductory Information Form, Psychological Well-being Scale, Perceived Stress Scale (PSS/PSS-14), State Trait Anxiety Inventory (STAI). The NST device is used to follow up pregnant women in the last 3 months of pregnancy, first monthly, then every two weeks and once a week. In other words, the procedure is routinely performed on every pregnant woman who comes for control. It is a device that shows the well-being of the baby and whether the mother has contractions. It is attached to the pregnant woman's abdominal area and does not cause any harm. It is not an invasive procedure. Pregnant women in the last 3 months of pregnancy who come to have NST for follow-up will be randomly selected and divided into 2 groups. A lamp with adjustable light level with Unit Unit Ut-383 Mini Luxmeter (Light Meter) will be placed in the intervention and control groups and the light level of the lamp will be adjusted to 100 lux. NST will be taken under cold (bluish white) light for the control group and under medium warm white (daylight white) light for the intervention group. Pre-test before the application and post-test after the application will be applied. The application is an invasive application that will not disturb the pregnant woman.

Interventions

  • Other Light intervention
    Light intervention

Primary outcome measures

  • stress scale [Time frame: 2 minutes]
  • anxiety scale [Time frame: 2 minutes]
  • psychological well-being scale [Time frame: 1 minutes]

Eligibility criteria

Inclusion criteria

  • Being at risk of pregnancy,
  • being in the last trimester of pregnancy,
  • being a volunteer.

Exclusion criteria

  • Having any problem that prevents communication (such as not knowing Turkish, having hearing, speaking and understanding disorders),
  • being on psychiatric treatment (pharmacotherapy or psychotherapy),
  • having a disease in their eyes that prevents them from seeing

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

Center list to be confirmed — check the primary protocol.

Publications

  • Yildirim E, Polat F. Light color temperature on stress, anxiety and well-being in high-risk pregnant women during the non-stress test: a randomized controlled trial. Reprod Health. 2026 Feb 24;23(1):50. doi: 10.1186/s12978-026-02280-6. PMID 41731583

Identifiers

NCT: NCT06736873 · 205323

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗